SCHEMBL13680457

SCHEMBL13680457

COc1ccc(-c2ccc(C)o2)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.49
CYP2A6 P11509 2/20 0.47
MKNK1 Q9BUB5 1/20 0.44
MKNK2 Q9HBH9 1/20 0.44
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HSD17B1 P14061 1/20 0.43
HSD17B2 P37059 1/20 0.43
PDGFRB P09619 1/20 0.42
PDGFRA P16234 1/20 0.42
PIK3CA P42336 1/20 0.40
TDO2 P48775 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
GSK3B P49841 1/20 0.40
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13680516 0.81 CYP1A2 (0.39) MAPTCYP2A6NPC1RAB9AGSK3B
SCHEMBL13680518 0.79 MAPT (0.41) MAPTNPC1RAB9APIK3CAGSK3B
SCHEMBL13680469 0.78 NPC1 (0.42) MAPTNPC1RAB9APIK3CATDO2
SCHEMBL31174412 0.77 CYP2A6 (0.68) CYP2A6MKNK1MKNK2CA1CA2
SCHEMBL3754419 0.77 CYP2A6 (0.68) CYP2A6MKNK1MKNK2CA1CA2
SCHEMBL13680455 0.75 CYP2A6 (0.45) MAPTCYP2A6NPC1RAB9AGSK3B
SCHEMBL15935065 0.75 MAPT (0.51) MAPTNPC1RAB9AGSK3BMEN1
SCHEMBL31288170 0.75 HDAC6 (0.45) CYP2A6MKNK1MKNK2CA1CA2
SCHEMBL13680715 0.74 TDP1 (0.42) MAPTNPC1RAB9AL3MBTL1GSK3B
SCHEMBL13680506 0.73 MAPK1 (0.51) MAPTL3MBTL1GSK3BMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582658-B2 Bicyclic compound ASAHI KASEI PHARMA CORPORATION (JP) 2009-09-01 US disclosed
US-7582658-B2 Bicyclic compound ASAHI KASEI PHARMA CORPORATION (JP) 2009-09-01 US disclosed